Clinical Trial Update: Fentanyl Buccal Tablet or Morphine for Exertional Dyspnea in Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 study evaluating fentanyl buccal tablet or morphine for exertional dyspnea in cancer patients is active but not recruiting, sponsored by MD Anderson Can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancy
• Solid Malignant Neoplasm

Drugs mentioned

• Fentanyl Buccal Tablet (fentanyl buccal tablet)
• Morphine (morphine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Phase 3 | Status: ACTIVE_NOT_RECRUITING